ONC
BeiGene, Ltd.
347.50$
-2.4%
vs. previous close
Closing price · As of: Aug 14, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.5% | -66.7% | -451.9% | -8,365.7% | 5.3% | -276.3% | -175.2% | -415.5% | -110.4% | -105.7% | -47.1% | -3.7% | 21.1% | |
| 14.3% | 11.9% | 17.5% | 178.4% | 2.0% | 5.2% | 4.3% | 10.3% | 3.9% | 4.7% | 3.6% | 4.5% | 2.7% | |
| -0.2% | 50.9% | 115.8% | 993.0% | 18.0% | 44.0% | 31.3% | 59.4% | 20.5% | 21.4% | 15.0% | 11.6% | 9.6% | |
| 69.5% | -11.8% | 25.7% | 1,319.6% | 24.0% | -8.7% | -2.5% | 48.8% | -10.1% | 9.4% | -15.1% | -4.1% | 3.6% | |
| 2.4% | 5.0% | 60.3% | 2,196.4% | 24.6% | 71.1% | 37.0% | 74.2% | 26.8% | 33.1% | 24.3% | 13.9% | 3.5% | |
| -2.2% | -258.1% | -668.2% | -20,733.5% | -149.5% | -321.7% | 129.4% | -1,025.8% | 54.5% | 76.1% | 2.4% | -14.4% | -5.2% | |
| – | -0.6% | -0.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | 8.6% | -4.7% | 14.7% | 3.8% | 0.1% | |
| -4.3% | 400.2% | 1,170.7% | 35,598.3% | 205.7% | 852.9% | 20.0% | 1,684.4% | 309.2% | -1.3% | 16.9% | 5.1% | 19.8% | |
| 29.6% | 76.5% | 45.0% | 6,508.9% | 63.8% | 252.8% | -28.0% | 249.0% | 254.4% | -35.9% | -28.0% | -14.4% | 36.9% | |
| 34.2% | -71.7% | -512.2% | -10,562.1% | -19.3% | -347.4% | -212.3% | -489.7% | -137.2% | -138.8% | -71.3% | -17.6% | 17.6% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.